NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $336,491 | +1.0% | 3,303 | 0.0% | 0.15% | +0.7% |
Q2 2023 | $333,306 | +9.7% | 3,303 | 0.0% | 0.15% | +5.5% |
Q1 2023 | $303,876 | +4.6% | 3,303 | +3.1% | 0.14% | -3.3% |
Q4 2022 | $290,576 | +19.6% | 3,203 | 0.0% | 0.15% | +5.6% |
Q3 2022 | $243,000 | -7.3% | 3,203 | +3.2% | 0.14% | -3.4% |
Q2 2022 | $262,000 | -4.4% | 3,103 | -0.7% | 0.15% | 0.0% |
Q1 2022 | $274,000 | +0.4% | 3,126 | 0.0% | 0.15% | 0.0% |
Q4 2021 | $273,000 | +6.6% | 3,126 | 0.0% | 0.15% | 0.0% |
Q3 2021 | $256,000 | -6.2% | 3,126 | +4.3% | 0.15% | -11.4% |
Q2 2021 | $273,000 | +18.7% | 2,996 | +11.1% | 0.17% | +12.2% |
Q1 2021 | $230,000 | -34.5% | 2,696 | -27.5% | 0.15% | -31.2% |
Q4 2020 | $351,000 | +12.1% | 3,719 | +3.3% | 0.22% | +0.5% |
Q3 2020 | $313,000 | +17.2% | 3,601 | +17.4% | 0.21% | +4.9% |
Q2 2020 | $267,000 | -1.8% | 3,066 | +6.5% | 0.20% | +0.5% |
Q4 2019 | $272,000 | – | 2,879 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |